← Back to Clinical Trials
Recruiting NCT07869680

NCT07869680 Functional Capacity Differences in Knee Osteoarthritis With Similar Pain Severity

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07869680
Status Recruiting
Phase —
Sponsor Mardin Artuklu University
Condition Knee Osteoarthritis
Study Type OBSERVATIONAL
Enrollment 120 participants
Start Date 2026-08-01
Primary Completion 2027-05-01

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 75 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 120 participants in total. It began in 2026-08-01 with a primary completion date of 2027-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

People with knee osteoarthritis may have similar levels of pain but very different abilities to walk, rise from a chair, and perform daily activities. This study aims to examine the factors associated with these differences in functional capacity among patients with similar knee pain severity. Adults with radiographic knee osteoarthritis and an average knee pain level of 4-6 on a 0-10 scale will be included. During a single study visit, participants will complete questionnaires about physical function, central sensitization-related symptoms, and physical activity. They will also perform a 10-meter walk test, a 30-second chair stand test, and the Timed Up and Go test. Self-reported physical function will be assessed using the function subscale of the Western Ontario and McMaster Universities Osteoarthritis Index. Participants with better and poorer function will be compared, and the clinical factors independently associated with functional capacity will be examined. No treatment or intervention will be assigned as part of this study.

Eligibility Criteria

Inclusion Criteria: * Age 40-75 years * Clinical and radiographic diagnosis of knee osteoarthritis * Kellgren-Lawrence grade 2 or 3 knee osteoarthritis * Knee pain lasting at least 3 months * Average knee pain intensity during the previous week between 4 and 6 on a 0-10 visual analog scale * Ability to provide written informed consent Exclusion Criteria: * Kellgren-Lawrence grade 1 or 4 knee osteoarthritis * Inflammatory rheumatic disease * History of knee surgery or intra-articular knee injection within the previous 6 months * Neurological disease that substantially affects knee function * Severe cardiopulmonary disease that prevents walking or performance testing * Cognitive impairment that prevents participation in the assessment procedures * For participants with bilateral knee osteoarthritis, assessments will be performed on the more painful knee.

Contact & Investigator

Central Contact

Taha Yasin YILDIRIM, M.D.

✉ tyasinyildirim.ftr@gmail.com

📞 +90 534 220 77 17

Frequently Asked Questions

Who can join the NCT07869680 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 75 Years, studying Knee Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07869680 currently recruiting?

Yes, NCT07869680 is actively recruiting participants. Contact the research team at tyasinyildirim.ftr@gmail.com for enrollment information.

Where is the NCT07869680 trial being conducted?

This trial is being conducted at Mardin, Turkey (Türkiye).

Who is sponsoring the NCT07869680 clinical trial?

NCT07869680 is sponsored by Mardin Artuklu University. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology